{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:01:08Z","timestamp":1754262068663,"version":"3.40.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008255","name":"Mustafa Kemal \u00dcniversitesi","doi-asserted-by":"publisher","award":["20.M.044"],"award-info":[{"award-number":["20.M.044"]}],"id":[{"id":"10.13039\/501100008255","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hatay Mustafa Kemal University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Familial Mediterranean fever (FMF) is a multifaceted autoimmune disease and requires a diligent strategical approach considering disease periods and mutation subtypes. We aimed to investigate serum levels of autoimmunity-related cell-free miRNAs and inflammatory and apoptotic markers in FMF patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Sixty FMF patients, of which 30 were in attack (FMF-A) and 30 were in remission (FMF-R) periods, and 25 age-, sex-, and BMI-matched healthy controls were included in our study. The expression levels of miR-26a-5p, miR-146a-5p, miR-155\u20132-5p, and miR-451a were analyzed with reverse-transcriptase quantitative polymerase chain reaction, and protein levels of interleukin-18 (IL18) and soluble Fas cell surface death receptor (sFAS) were measured with enzyme-linked immunosorbent assay. Serum CRP levels were analyzed by nephelometry, ferritin levels by chemiluminescence, and routine biochemical parameters by spectrophotometry. Correlation analyses were performed to seek potential associations of miRNAs with serum markers and biochemical parameters. Potential biomarkers were tested with receiver operating characteristic analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We observed elevated serum IL18 levels but not sFAS, in FMF patients, particularly during attack period. IL18 demonstrated diagnostic value and was significantly correlated with acute-phase markers namely CRP, fibrinogen, and ferritin. Altered levels of IL18 and miR-451a could distinguish FMF patients in the attack period from the ones in remission. miR-26a-5p, miR-146a-5p, and miR-155\u20132-5p were downregulated in FMF patients carrying M694V mutations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings suggest that IL18 and specific miRNAs can serve as potential biomarkers for FMF pathogenesis. Discovering promising targets for FMF-related miRNAs using mechanistic strategies will enhance our understanding of FMF disease management and therapy.<\/jats:p>\n            <jats:p>\n              <jats:table-wrap>\n                <jats:table>\n                  <jats:tbody>\n                    <jats:tr>\n                      <jats:td align=\"left\">Key Points<\/jats:td>\n                    <\/jats:tr>\n                    <jats:tr>\n                      <jats:td align=\"left\">\u2022 <jats:italic>miR-451a and IL18 can serve as an indicator in distinguishing familial Mediterranean fever patients in attack and remission periods<\/jats:italic>.\u2022 <jats:italic>miR-26a-5p, miR-146a-5p, and miR-155\u20132-5p were dysregulated in FMF patients carrying M694V mutation<\/jats:italic>.<\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody>\n                <\/jats:table>\n              <\/jats:table-wrap>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10067-025-07359-2","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:09:14Z","timestamp":1739293754000},"page":"1691-1704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["miR-451a and IL18 can differentiate familial Mediterranean fever patients in attack and remission periods: a prospective cross-sectional study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-0451","authenticated-orcid":false,"given":"Menderes Yusuf","family":"Terzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u011fuzhan","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gezmi\u015f","family":"Kimyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza Malik","family":"Okuyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Arpac\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"2","key":"7359_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43(2):227\u2013253. https:\/\/doi.org\/10.1016\/0002-9343(67)90167-2","journal-title":"Am J Med"},{"issue":"6","key":"7359_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.55563\/clinexprheumatol\/4iiab4","volume":"Suppl 108","author":"YZ Akkaya-Ulum","year":"2017","unstructured":"Akkaya-Ulum YZ, Balci-Peynircioglu B, Karadag O, Eroglu FK, Kalyoncu U, Kiraz S, Ertenli AI, Ozen S, Yilmaz E (2017) Alteration of the microRNA expression profile in familial Mediterranean fever patients. Clin Exp Rheumatol Suppl 108(6):90\u201394. https:\/\/doi.org\/10.55563\/clinexprheumatol\/4iiab4","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"7359_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/sj.ejhg.5200672","volume":"9","author":"R Gershoni-Baruch","year":"2001","unstructured":"Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R (2001) Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 9(8):634\u2013637. https:\/\/doi.org\/10.1038\/sj.ejhg.5200672","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"7359_CR4","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1182\/blood-2008-01-134932","volume":"112","author":"JJ Chae","year":"2008","unstructured":"Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 112(5):1794\u20131803. https:\/\/doi.org\/10.1182\/blood-2008-01-134932","journal-title":"Blood"},{"issue":"6","key":"7359_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20142384","volume":"212","author":"ML Kim","year":"2015","unstructured":"Kim ML, Chae JJ, Park YH, De Nardo D, Stirzaker RA, Ko HJ, Tye H, Cengia L, DiRago L, Metcalf D, Roberts AW, Kastner DL, Lew AM, Lyras D, Kile BT, Croker BA, Masters SL (2015) Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1beta. J Exp Med 212(6):927\u2013938. https:\/\/doi.org\/10.1084\/jem.20142384","journal-title":"J Exp Med"},{"key":"7359_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fmicb.2016.00456","volume":"7","author":"G Manukyan","year":"2016","unstructured":"Manukyan G, Aminov R (2016) Update on pyrin functions and mechanisms of familial Mediterranean fever. Front Microbiol 7:456. https:\/\/doi.org\/10.3389\/fmicb.2016.00456","journal-title":"Front Microbiol"},{"issue":"6","key":"7359_CR7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/art.24569","volume":"60","author":"MG Booty","year":"2009","unstructured":"Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, Barron KS, Holland SM, Kastner DL, Aksentijevich I (2009) Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 60(6):1851\u20131861. https:\/\/doi.org\/10.1002\/art.24569","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7359_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/jhg.2010.52","volume":"55","author":"MM Moradian","year":"2010","unstructured":"Moradian MM, Sarkisian T, Ajrapetyan H, Avanesian N (2010) Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet 55(6):389\u2013393. https:\/\/doi.org\/10.1038\/jhg.2010.52","journal-title":"J Hum Genet"},{"key":"7359_CR9","first-page":"295","volume-title":"Academic Studies in Health Sciences-II","author":"MY Terzi","year":"2020","unstructured":"Terzi MY (2020) Clinical significance of miRNAs: a valuable diagnostic, prognostic, therapeutic tool. In: Sar\u0131 \u00d6 (ed) Academic Studies in Health Sciences-II, 1st edn. Gece Publishing, Ankara, pp 295\u2013310","edition":"1"},{"issue":"6","key":"7359_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.23880","volume":"73","author":"R Gandhi","year":"2013","unstructured":"Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729\u2013740. https:\/\/doi.org\/10.1002\/ana.23880","journal-title":"Ann Neurol"},{"issue":"12","key":"7359_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","volume":"12","author":"RP Singh","year":"2013","unstructured":"Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH, Rehimi H (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12(12):1160\u20131165. https:\/\/doi.org\/10.1016\/j.autrev.2013.07.003","journal-title":"Autoimmun Rev"},{"issue":"5","key":"7359_CR12","doi-asserted-by":"publisher","first-page":"e0197829","DOI":"10.1371\/journal.pone.0197829","volume":"13","author":"G Amarilyo","year":"2018","unstructured":"Amarilyo G, Pillar N, Ben-Zvi I, Weissglas-Volkov D, Zalcman J, Harel L, Livneh A, Shomron N (2018) Analysis of microRNAs in familial Mediterranean fever. PLoS ONE 13(5):e0197829. https:\/\/doi.org\/10.1371\/journal.pone.0197829","journal-title":"PLoS ONE"},{"key":"7359_CR13","doi-asserted-by":"publisher","unstructured":"Demir F, Cebi AH, Kalyoncu M (2020) Assessment of circulating microribonucleic acids in patients with familial Mediterranean fever. Archives of Rheumatology 35(1):52\u201359. https:\/\/doi.org\/10.5606\/ArchRheumatol.2020.7414","DOI":"10.5606\/ArchRheumatol.2020.7414"},{"issue":"3","key":"7359_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10067-017-3914-0","volume":"38","author":"HO Hortu","year":"2019","unstructured":"Hortu HO, Karaca E, Sozeri B, Gulez N, Makay B, Gunduz C, Atik T, Tekin IM, Unsal SE, Cogulu O (2019) Evaluation of the effects of miRNAs in familial Mediterranean fever. Clin Rheumatol 38(3):635\u2013643. https:\/\/doi.org\/10.1007\/s10067-017-3914-0","journal-title":"Clin Rheumatol"},{"key":"7359_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04541-4","author":"EM Karpuzoglu","year":"2020","unstructured":"Karpuzoglu EM, KislaEkinci RM, Balci S, Bisgin A, Yilmaz M (2020) Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study. Rheumatol Int 41:103\u2013111. https:\/\/doi.org\/10.1007\/s00296-020-04541-4","journal-title":"Rheumatol Int"},{"issue":"16","key":"7359_CR16","doi-asserted-by":"publisher","first-page":"e3449","DOI":"10.1097\/MD.0000000000003449","volume":"95","author":"T Koga","year":"2016","unstructured":"Koga T, Migita K, Sato S, Umeda M, Nonaka F, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura K, Eguchi K, Kawakami A (2016) Multiple serum cytokine profiling to identify combinational diagnostic biomarkers in attacks of familial Mediterranean fever. Medicine (Baltimore) 95(16):e3449. https:\/\/doi.org\/10.1097\/MD.0000000000003449","journal-title":"Medicine (Baltimore)"},{"issue":"10\u201311","key":"7359_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.clinbiochem.2008.03.017","volume":"41","author":"GP Manukyan","year":"2008","unstructured":"Manukyan GP, Ghazaryan KA, Ktsoyan ZhA, Tatyan MV, Khachatryan ZA, Hakobyan GS, Mkrtchyan VA, Kelly D, Coutts A, Aminov RI (2008) Cytokine profile of Armenian patients with familial Mediterranean fever. Clin Biochem 41(10\u201311):920\u2013922. https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.03.017","journal-title":"Clin Biochem"},{"issue":"4","key":"7359_CR18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/rheumatology\/kex451","volume":"57","author":"T Koga","year":"2018","unstructured":"Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A (2018) MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase gamma pathway. Rheumatology (Oxford) 57(4):718\u2013726. https:\/\/doi.org\/10.1093\/rheumatology\/kex451","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"7359_CR19","doi-asserted-by":"publisher","first-page":"e32439","DOI":"10.1371\/journal.pone.0032439","volume":"7","author":"M Abdgawad","year":"2012","unstructured":"Abdgawad M, Pettersson A, Gunnarsson L, Bengtsson AA, Geborek P, Nilsson L, Segelmark M, Hellmark T (2012) Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis. PLoS ONE 7(3):e32439. https:\/\/doi.org\/10.1371\/journal.pone.0032439","journal-title":"PLoS ONE"},{"issue":"12","key":"7359_CR20","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s10067-017-3615-8","volume":"36","author":"BL Liphaus","year":"2017","unstructured":"Liphaus BL, Kiss MHB, Carrasco S, Palmeira P, Goldenstein-Schainberg C, Carneiro-Sampaio M (2017) Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus. Clin Rheumatol 36(12):2847\u20132852. https:\/\/doi.org\/10.1007\/s10067-017-3615-8","journal-title":"Clin Rheumatol"},{"issue":"10","key":"7359_CR21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879\u20131885. https:\/\/doi.org\/10.1002\/art.1780401023","journal-title":"Arthritis Rheum"},{"key":"7359_CR22","doi-asserted-by":"publisher","first-page":"101780","DOI":"10.1016\/j.genrep.2023.101780","volume":"31","author":"HM Okuyan","year":"2023","unstructured":"Okuyan HM, Terzi MY, Dogan S, Emir T, Turgut FH (2023) Association of miR-21\u20135p with routine biochemical markers and inflammatory cytokines in hemodialysis patients. Gene Reports 31:101780. https:\/\/doi.org\/10.1016\/j.genrep.2023.101780","journal-title":"Gene Reports"},{"issue":"D1","key":"7359_CR23","doi-asserted-by":"publisher","first-page":"D1327","DOI":"10.1093\/nar\/gkad717","volume":"52","author":"C Cui","year":"2024","unstructured":"Cui C, Zhong B, Fan R, Cui Q (2024) HMDD v4.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res 52(D1):D1327\u2013D1332. https:\/\/doi.org\/10.1093\/nar\/gkad717","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"7359_CR24","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/14397595.2020.1868674","volume":"31","author":"HM Okuyan","year":"2021","unstructured":"Okuyan HM, Begen MA (2021) miRNAs as attractive diagnostic and therapeutic targets for familial Mediterranean fever. Mod Rheumatol 31(5):949\u2013959. https:\/\/doi.org\/10.1080\/14397595.2020.1868674","journal-title":"Mod Rheumatol"},{"issue":"2","key":"7359_CR25","first-page":"313","volume":"30","author":"S Kiraz","year":"2003","unstructured":"Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Calguneri M, Atalar E, Ozbalkan Z, Kirazli S, Celik I (2003) Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis. J Rheumatol 30(2):313\u2013315","journal-title":"J Rheumatol"},{"issue":"4 Suppl 38","key":"7359_CR26","first-page":"S77","volume":"23","author":"S Haznedaroglu","year":"2005","unstructured":"Haznedaroglu S, Ozturk MA, Sancak B, Goker B, Onat AM, Bukan N, Ertenli I, Kiraz S, Calguneri M (2005) Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 23(4 Suppl 38):S77-80","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"7359_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00296-006-0301-6","volume":"27","author":"I Simsek","year":"2007","unstructured":"Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27(9):807\u2013811. https:\/\/doi.org\/10.1007\/s00296-006-0301-6","journal-title":"Rheumatol Int"},{"issue":"3","key":"7359_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","volume":"20","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Nakanishi K, Tsutsui H (2019) Interleukin-18 in health and disease. Int J Mol Sci 20(3):649. https:\/\/doi.org\/10.3390\/ijms20030649","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7359_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.cir.0000020546.30940.92","volume":"106","author":"S Blankenberg","year":"2002","unstructured":"Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ, AtheroGene I (2002) Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106(1):24\u201330. https:\/\/doi.org\/10.1161\/01.cir.0000020546.30940.92","journal-title":"Circulation"},{"issue":"2","key":"7359_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaut.2009.08.002","volume":"34","author":"D Novick","year":"2010","unstructured":"Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, Sthoeger ZM (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34(2):121\u2013126. https:\/\/doi.org\/10.1016\/j.jaut.2009.08.002","journal-title":"J Autoimmun"},{"key":"7359_CR31","doi-asserted-by":"publisher","first-page":"728417","DOI":"10.1155\/2012\/728417","volume":"2012","author":"B Shi","year":"2012","unstructured":"Shi B, Ni Z, Cao L, Zhou M, Mou S, Wang Q, Zhang M, Fang W, Yan Y, Qian J (2012) Serum IL-18 is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA nephropathy. Mediators Inflamm 2012:728417. https:\/\/doi.org\/10.1155\/2012\/728417","journal-title":"Mediators Inflamm"},{"issue":"6","key":"7359_CR32","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/14397595.2017.1285845","volume":"27","author":"T Wada","year":"2017","unstructured":"Wada T, Toma T, Matsuda Y, Yachie A, Itami S, Taguchi YH, Murakami Y (2017) Microarray analysis of circulating microRNAs in familial Mediterranean fever. Mod Rheumatol 27(6):1040\u20131046. https:\/\/doi.org\/10.1080\/14397595.2017.1285845","journal-title":"Mod Rheumatol"},{"issue":"2","key":"7359_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10753-017-0514-8","volume":"40","author":"J Cheng","year":"2017","unstructured":"Cheng J, Wu R, Long L, Su J, Liu J, Wu XD, Zhu J, Zhou B (2017) miRNA-451a targets IFN regulatory factor 8 for the progression of systemic lupus erythematosus. Inflammation 40(2):676\u2013687. https:\/\/doi.org\/10.1007\/s10753-017-0514-8","journal-title":"Inflammation"},{"issue":"12","key":"7359_CR34","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.4049\/jimmunol.1201437","volume":"189","author":"CM Rosenberger","year":"2012","unstructured":"Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A (2012) miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 189(12):5965\u20135975. https:\/\/doi.org\/10.4049\/jimmunol.1201437","journal-title":"J Immunol"},{"key":"7359_CR35","doi-asserted-by":"publisher","first-page":"2180913","DOI":"10.1155\/2020\/2180913","volume":"2020","author":"DS Fotoh","year":"2020","unstructured":"Fotoh DS, Noreldin RI, Rizk MS, Elsabaawy MM, Esaily HA (2020) miRNA-451a and miRNA-125a expression levels in ankylosing spondylitis: impact on disease diagnosis, prognosis, and outcomes. J Immunol Res 2020:2180913. https:\/\/doi.org\/10.1155\/2020\/2180913","journal-title":"J Immunol Res"},{"issue":"5","key":"7359_CR36","doi-asserted-by":"publisher","first-page":"e20240068","DOI":"10.1590\/1806-9282.20240068","volume":"70","author":"I Atik","year":"1992","unstructured":"Atik I (1992) Atik S (2024) Relationship between sacroiliitis and inflammatory markers in familial Mediterranean fever. Rev Assoc Med Bras 70(5):e20240068. https:\/\/doi.org\/10.1590\/1806-9282.20240068","journal-title":"Rev Assoc Med Bras"},{"issue":"5","key":"7359_CR37","first-page":"477","volume":"27","author":"Y Xiang","year":"2011","unstructured":"Xiang Y, Jiang MH, Wang DS, Gao J, Zhang YX, Liu YX, Zheng DX (2011) Effect of miR-146a on IL-18 expression in mouse macrophage. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(5):477\u2013479","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"3","key":"7359_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI84424","volume":"127","author":"BD Adams","year":"2017","unstructured":"Adams BD, Parsons C, Walker L, Zhang WC, Slack FJ (2017) Targeting noncoding RNAs in disease. J Clin Invest 127(3):761\u2013771. https:\/\/doi.org\/10.1172\/JCI84424","journal-title":"J Clin Invest"},{"issue":"27","key":"7359_CR39","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108(27):11193\u201311198. https:\/\/doi.org\/10.1073\/pnas.1019536108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7359_CR40","doi-asserted-by":"publisher","unstructured":"Chen L, Liu C, Xiang X, Qiu W, Guo K (2024) miR\u2011155 promotes an inflammatory response in HaCaT cells via the IRF2BP2\/KLF2\/NF\u2011kappaB pathway in psoriasis. Int J Mol Med 54(5):91. https:\/\/doi.org\/10.3892\/ijmm.2024.5415","DOI":"10.3892\/ijmm.2024.5415"},{"key":"7359_CR41","doi-asserted-by":"publisher","first-page":"113013","DOI":"10.1016\/j.intimp.2024.113013","volume":"141","author":"J Yu","year":"2024","unstructured":"Yu J, Mei J, Zuo D, Zhang M, Yu S, Li F, Wang J, Bi D, Ma S, Wang J, Yin ZJ (2024) Inflammatory factor-mediated miR-155\/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus. Int Immunopharmacol 141:113013. https:\/\/doi.org\/10.1016\/j.intimp.2024.113013","journal-title":"Int Immunopharmacol"},{"key":"7359_CR42","doi-asserted-by":"publisher","first-page":"984302","DOI":"10.3389\/fimmu.2022.984302","volume":"13","author":"JK King","year":"2022","unstructured":"King JK, Tran TM, Paing MH, Yin Y, Jaiswal AK, Tso CH, Roy K, Casero D, Rao DS (2022) Regulation of T-independent B-cell responses by microRNA-146a. Front Immunol 13:984302. https:\/\/doi.org\/10.3389\/fimmu.2022.984302","journal-title":"Front Immunol"},{"issue":"4","key":"7359_CR43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/art.24436","volume":"60","author":"Y Tang","year":"2009","unstructured":"Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60(4):1065\u20131075. https:\/\/doi.org\/10.1002\/art.24436","journal-title":"Arthritis Rheum"},{"issue":"12","key":"7359_CR44","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/jbmr.2002","volume":"28","author":"X Li","year":"2013","unstructured":"Li X, Kroin JS, Kc R, Gibson G, Chen D, Corbett GT, Pahan K, Fayyaz S, Kim JS, van Wijnen AJ, Suh J, Kim SG, Im HJ (2013) Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res 28(12):2512\u20132522. https:\/\/doi.org\/10.1002\/jbmr.2002","journal-title":"J Bone Miner Res"},{"key":"7359_CR45","doi-asserted-by":"publisher","first-page":"991425","DOI":"10.3389\/fmolb.2022.991425","volume":"9","author":"S Li","year":"2022","unstructured":"Li S, Han Y, Zhang Q, Tang D, Li J, Weng L (2022) Comprehensive molecular analyses of an autoimmune-related gene predictive model and immune infiltrations using machine learning methods in moyamoya disease. Front Mol Biosci 9:991425. https:\/\/doi.org\/10.3389\/fmolb.2022.991425","journal-title":"Front Mol Biosci"},{"issue":"1","key":"7359_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12017-014-8335-5","volume":"17","author":"R Zhang","year":"2015","unstructured":"Zhang R, Tian A, Wang J, Shen X, Qi G, Tang Y (2015) miR26a modulates Th17\/T reg balance in the EAE model of multiple sclerosis by targeting IL6. Neuromolecular Med 17(1):24\u201334. https:\/\/doi.org\/10.1007\/s12017-014-8335-5","journal-title":"Neuromolecular Med"},{"key":"7359_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nbd.2019.01.019","volume":"125","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang ZG, Lu M, Zhang Y, Shang X, Chopp M (2019) MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis. Neurobiol Dis 125:154\u2013162. https:\/\/doi.org\/10.1016\/j.nbd.2019.01.019","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"7359_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","volume":"266","author":"J Zhang","year":"2014","unstructured":"Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266(1\u20132):56\u201363. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.019","journal-title":"J Neuroimmunol"},{"issue":"3","key":"7359_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08916934.2019.1710135","volume":"53","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wu H, Zhao M, Lu Q (2020) Identifying the differentially expressed microRNAs in autoimmunity: a systemic review and meta-analysis. Autoimmunity 53(3):122\u2013136. https:\/\/doi.org\/10.1080\/08916934.2019.1710135","journal-title":"Autoimmunity"},{"issue":"1","key":"7359_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-015-0215-0","volume":"39","author":"H Ma","year":"2016","unstructured":"Ma H, Zhang S, Shi D, Mao Y, Cui J (2016) MicroRNA-26a promotes regulatory T cells and suppresses autoimmune diabetes in mice. Inflammation 39(1):1\u20139. https:\/\/doi.org\/10.1007\/s10753-015-0215-0","journal-title":"Inflammation"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07359-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07359-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07359-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T10:55:00Z","timestamp":1744455300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07359-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7359"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07359-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Hatay Mustafa Kemal University Ethical Board (Approval no: 2020\/73).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors approved the present work for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors declare that they have no financial or nonfinancial conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consents were acquired from the participants in the present study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}